Alfonso Rodríguez-Gil

6PUBLICATIONS
19CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMicro-manipulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 09, 2026
Neuroinflammatory and Motor Alterations in LRRK2*G2019S Transgenic Mice Without Enhanced Vulnerability to Aging or Chronic MPTP-Induced Nigrostriatal Neurodegeneration.

|Mar 31, 2026
BCL2 overexpression in donor lymphocytes reduces the risk of graft-versus-host disease.

Jose Antonio Bejarano-Garcia, Melanie Nufer, Mª José Palacios-Barea

|Mar 21, 2025
Sorafenib-associated translation reprogramming in hepatocellular carcinoma cells.

Laura Contreras, Alfonso Rodríguez-Gil, Jordi Muntané

|May 28, 2022
Effect of Vitamin D on Graft-versus-Host Disease.

Alfonso Rodríguez-Gil, Estrella Carrillo-Cruz, Cristina Marrero-Cepeda

|Mar 10, 2022
Broad Transcriptomic Impact of Sorafenib and Its Relation to the Antitumoral Properties in Liver Cancer Cells.

Laura Contreras, Alfonso Rodríguez-Gil, Jordi Muntané

|Jun 16, 2017
The CCR4-NOT complex contributes to repression of Major Histocompatibility Complex class II transcription.

Alfonso Rodríguez-Gil, Olesja Ritter, Vera V Saul

Pageof 1

Frequent Collaborators

2 joint publications

Jordi Muntané

2 joint publications

Jesús de la Cruz

1 joint publications

José A Pérez-Simón

1 joint publications

Laura Contreras